{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-024108","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.391914+00:00","generated_at":"2026-06-01T04:07:14.042600+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Oncocyte appoints Andrea James as CFO, effective June 17, 2024","bullets":["Andrea James appointed CFO; previously Chief Communications Officer at Axon Enterprise (AXON) and IR roles at Tesla.","Compensation: $325,000 base salary, 50% target bonus; option for 200,000 shares and 100,000 RSUs (subject to shareholder approval).","CEO Josh Riggs cites James' experience in capital raising and IR as company nears commercial launch.","James Liu remains Senior Director, Controller & Principal Accounting Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-024108","json":"https://secwatch.observer/filing/0001493152-24-024108.json","markdown":"https://secwatch.observer/filing/0001493152-24-024108.md","text":"https://secwatch.observer/filing/0001493152-24-024108.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315224024108/0001493152-24-024108-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315224024108/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:07:14.042600+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0866438761","claim":"Andrea James was appointed as Chief Financial Officer at Insight Molecular Diagnostics Inc..","evidence_excerpt":"On June 17, 2024, the Board of Directors (the “Board”) of Oncocyte Corporation (the “Company”) appointed Andrea James to serve as the Company’s Chief Financial Officer, effective June 17, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315224024108/0001493152-24-024108-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}